SATURDAY, AUGUST 19, 2017

MIPS program awards $4.7 million for development of technology products

The University of Maryland's Maryland Industrial Partnerships program recently announced that it is awarding $4.7 million to Maryland university researchers to aid 16 local companies in developing important technology products. Read More »

Novartis and Vasella agree to cancel non-compete and related compensation

Novartis announced an agreement on Tuesday to cancel a non-compete agreement with Daniel Vasella, the former chairman of the Novartis board of directors. Read More »

Celgene advances stock buyback plans

Celgene Corporation recently announced plans to carry out an accelerated share repurchase strategy as it looks to optimize its capital structure and increase its share value. Read More »

Biotechs sell hemophilia B vaccine

Biotechs Ipsen and Inspiration Biopharmaceuticals recently announced the final sale of their proprietary vaccine for hemophilia B to Cangene Corporation. Read More »

Chimerix names Ernest Mario as next chairman of the board

Chimerix, Inc., a Durham, N.C.-based biopharmaceutical company developing novel antivirals, announced the appointment on Wednesday of Ernest Mario as chairman of its board of directors. Read More »

Cangene closes acquisition of investigational hemophilia B product

Cangene Corporation, a Winnipeg, Canada-based biopharmaceutical company, announced on Wednesday the closing of the acquisition of an investigational hemophilia compound and certain other assets from Ipsen and Inspiration Biopharmaceuticals, Inc. Read More »

ACIP holds meeting to discuss vaccine updates, influenza

The U.S. Centers for Disease Control and Prevention's vaccine advisory board recently held a meeting to discuss recommendations for a variety of new vaccines. Read More »

Abbot, Janssen and Pharmacyclics team up for leukemia treatment

Abbott Laboratories recently announced plans to collaborate with Janssen Biotech, Inc., and Pharmacyclics, Inc., on a project using its proprietary fluorescence in situ hybridization technology. Read More »

Report: Bacteria become resistant to drugs when stressed

Olivier Tenaillon Read More »

Flu vaccine effective in 56 percent of cases

This season's flu vaccine was effective in only 56 percent of people who received the shot and completely failed in protecting the elderly against one of the strains, according to a recent analysis. Read More »

Ambit Biosciences planning IPO

Ambit Biosciences recently announced plans to raise approximately $86 million in an initial public offering formulated to support the late-stage development of the acute myeloid leukemia drug quizartinib. Read More »

Doctors Without Borders warns about rising immunization prices

The international aid organization Doctors Without Borders recently warned that high prices could prevent children around the world from being properly immunized. Read More »

Adimab looks to pay off VCs without IPO

Adimab, a Lebanon, New Hampshire-based antibody drug discovery company, is attempting to pay back approximately $40 million raised in venture capital without an initial public offering or selling out to a major pharmaceutical company. Read More »

U.S. releases stricter research rules for dangerous pathogens

The U.S. federal government released two documents on Thursday that detail stricter requirements for government and institution oversight of studies with pathogens that pose potential safety concerns. Read More »

Bavarian Nordic to host congresswoman to discuss public-private partnerships

Anna Eshoo Read More »

U.K. Diamond Light Source to study viral structures in detail

Dave Stuart Read More »

Poor cold chain facilities linked to Pakistani polio cases

Polio Read More »

Reviewing vaccination policy with employees can increase compliance

Creating and reviewing an influenza immunization policy with healthcare workers may increase compliance and prevent the spread of the flu virus at healthcare facilities, according to a New Hampshire health official. Read More »

FDA refuses adult approval for hepatitis B vaccine

Dynavax Technologies, Inc., may be forced to target its newly developed hepatitis B vaccine to a smaller market after U.S. health regulators denied the vaccine's approval for adults. Read More »

UNICEF launches major vaccination program in India

The United Nations Children's Fund recently launched a year-long vaccination campaign in India to raise awareness about the need for routine and anti-polio vaccinations. Read More »